Tracking actinic keratosis of face and scalp treated with 0.015% ingenol mebutate to identify clinical and dermoscopic predictors of treatment response.
R PampenaE BenatiS BorsariC BombonatoM LombardiM RaucciM MirraA LallasZ ApallaI PapadimitriouE MoscarellaA KyrgidisG ArgenzianoG PellacaniCaterina LongoPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2018)
Specific dermoscopic features of AK may predict the response to 0.015% IngMeb therapy, together with the location on the face.